166 related articles for article (PubMed ID: 25243947)
21. Primary choriocarcinoma of the stomach and pancreas: CT findings.
Coşkun M; Ağildere AM; Boyvat F; Tarhan C; Niron EA
Eur Radiol; 1998; 8(8):1425-8. PubMed ID: 9853229
[TBL] [Abstract][Full Text] [Related]
22. Comment on: "Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT".
Salavati A; Saboury B; Alavi A
J Nucl Med; 2014 Feb; 55(2):350-1. PubMed ID: 24323814
[No Abstract] [Full Text] [Related]
23. Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic Cancer.
Pimiento JM; Davis-Yadley AH; Kim RD; Chen DT; Eikman EA; Berman CG; Malafa MP
Clin Nucl Med; 2016 Mar; 41(3):177-81. PubMed ID: 26673243
[TBL] [Abstract][Full Text] [Related]
24. Reply: Comment on: "Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT".
Dimitrakopoulou-Strauss A; Frenkel A; Epelbaum R
J Nucl Med; 2014 Feb; 55(2):351-2. PubMed ID: 24323815
[No Abstract] [Full Text] [Related]
25. The value of (18)F-FDG PET/CT in the diagnosis of uterine intravenous leiomyomatosis extended into the right atrium.
Xiao J; Liu G; Cheng D; Wang H; Shi H
Hell J Nucl Med; 2016; 19(2):179-81. PubMed ID: 27331217
[TBL] [Abstract][Full Text] [Related]
26. Adenocarcinoma of the Cervix Uteri and Endometrium Combined With the Kartagener Syndrome on FDG PET/CT.
Zhang Y; Chen Y; Huang Z; Zhou F
Clin Nucl Med; 2015 Nov; 40(11):922-3. PubMed ID: 26284775
[TBL] [Abstract][Full Text] [Related]
27. ¹⁸F-fluorodeoxyglucose PET/CT features and correlations with histopathologic characteristics in sclerosing epithelioid fibrosarcoma.
Luo Y; Hu W; Wu H; Xue H; Huo L; Li F; Zhao Y; Dai M
Int J Clin Exp Pathol; 2014; 7(10):7278-85. PubMed ID: 25400826
[TBL] [Abstract][Full Text] [Related]
28. Placental-site trophoblastic tumor and fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography.
Çerçi SS; Erdemoglu E; Bozkurt KK; Yalçn Y; Erdemoglu E
Hell J Nucl Med; 2015; 18(3):264-7. PubMed ID: 26574698
[TBL] [Abstract][Full Text] [Related]
29. Metastatic choriocarcinoma to the pancreas.
Alvarez NR; Lambrou N; Solorzano CC
Am Surg; 2005 Apr; 71(4):330-2. PubMed ID: 15943408
[TBL] [Abstract][Full Text] [Related]
30. The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in follow-up of curatively resected pancreatic cancer patients.
Jung W; Jang JY; Kang MJ; Chang YR; Shin YC; Chang J; Kim SW
HPB (Oxford); 2016 Jan; 18(1):57-64. PubMed ID: 26776852
[TBL] [Abstract][Full Text] [Related]
31. [Choriocarcinoma of the uterus after term pregnancy: imaging by vaginal color Doppler ultrasound].
Hönigl W; Reich O; Ranner G; Pickel H
Ultraschall Med; 1997 Aug; 18(4):165-8. PubMed ID: 9381124
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic involvement detected with (18)F-FDG PET/CT in disseminated sarcoidosis.
Delgado-Bolton RC; Arias Navalón JA; Rodríguez Alfonso B; Delgado-Bolton AN; Pérez-Castejón MJ; Sánchez-Escribano R; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
Rev Esp Med Nucl; 2011; 30(1):29-32. PubMed ID: 20638156
[TBL] [Abstract][Full Text] [Related]
33. 18F-FDG PET/CT findings in uterine leiomyomas.
Jehanno N; Wartski M; Malhaire C; Fréneaux P; Petras S; Alberini JL
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):1034-5. PubMed ID: 24562644
[No Abstract] [Full Text] [Related]
34. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
Dalah E; Moraru I; Paulson E; Erickson B; Li XA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
[TBL] [Abstract][Full Text] [Related]
35. Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT).
Cameron K; Golan S; Simpson W; Peti S; Roayaie S; Labow D; Kostakoglu L
Abdom Imaging; 2011 Aug; 36(4):463-71. PubMed ID: 21465110
[TBL] [Abstract][Full Text] [Related]
36. F-18 FDG PET/CT of a uterine smooth-muscle tumor of unknown malignant potential.
Hong IK; Kim DY
Clin Nucl Med; 2011 Oct; 36(10):934-6. PubMed ID: 21892053
[No Abstract] [Full Text] [Related]
37. Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for the detection of skeletal muscle and skin metastases in uterine leiomyosarcoma: a case report.
Ozdemir E; Poyraz NY; Uzun B; Türkölmez S
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):257-9. PubMed ID: 23153988
[TBL] [Abstract][Full Text] [Related]
38. Staging accuracy of pancreatic cancer: comparison between non-contrast-enhanced and contrast-enhanced PET/CT.
Yoneyama T; Tateishi U; Endo I; Inoue T
Eur J Radiol; 2014 Oct; 83(10):1734-9. PubMed ID: 25043494
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: a meta-analysis.
Rijkers AP; Valkema R; Duivenvoorden HJ; van Eijck CH
Eur J Surg Oncol; 2014 Jul; 40(7):794-804. PubMed ID: 24755095
[TBL] [Abstract][Full Text] [Related]
40. The value of 18F-FDG positron emission tomography/computed tomography on the pre-operative staging and the management of patients with pancreatic carcinoma.
Wang XY; Yang F; Jin C; Guan YH; Zhang HW; Fu DL
Hepatogastroenterology; 2014 Oct; 61(135):2102-9. PubMed ID: 25722999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
